SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-013115 to Next.e.GO N.V. (EGOXF) (CIK 0001942808)

Next.e.GO N.V. (EGOXF) (CIK 0001942808)
Date: Dec. 1, 2023 · CIK: 0001942808 · Accession: 0000000000-23-013115

AI Filing Summary & Sentiment

File numbers found in text: 333-275553

Date
December 1, 2023
Author
Not clearly detected
Form
UPLOAD
Company
Next.e.GO N.V. (EGOXF) (CIK 0001942808)

Letter

United States securities and exchange commission logo December 1, 2023 Eelco Van Der Leij Executive Director Next.e.GO N.V. Lilienthalstraße 1 52068 Aachen, Germany Next.e.GO N.V. Re:Next.e.GO N.V. Registration Statement on Form F-1 Filed November 14, 2023 File No. 333-275553 Dear Eelco Van Der Leij: We have conducted a limited review of your registration statement and have the following comments. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Form F-1 filed November 14, 2023 Cover Page 1.For each of the securities being registered for resale, disclose the price that the selling securityholders paid for such securities. 2.Disclose the exercise price of the warrants compared to the market price of the underlying security. If the warrants are out the money, please disclose the likelihood that warrant holders will not exercise their warrants. Provide similar disclosure in the prospectus summary, risk factors, MD&A and use of proceeds section and disclose that cash proceeds associated with the exercises of the warrants are dependent on the stock price. As applicable, describe the impact on your liquidity and update the discussion on the ability of your company to fund your operations on a prospective basis with your current cash on hand.

FirstName LastNameEelco Van Der Leij Comapany NameNext.e.GO N.V. December 1, 2023 Page 2 FirstName LastNameEelco Van Der Leij Next.e.GO N.V. December 1, 2023 Page 2 3.We note the significant number of redemptions of your common stock in connection with your business combination and that the shares being registered for resale will constitute a considerable percentage of your public float. We also note that all or most of the shares being registered for resale were purchased by the selling securityholders for prices considerably below the current market price of the common stock. Highlight the significant negative impact sales of shares on this registration statement could have on the public trading price of the common stock. Risk Factors, page 18 4.Include an additional risk factor highlighting the negative pressure potential sales of shares pursuant to this registration statement could have on the public trading price of the common stock. To illustrate this risk, disclose the purchase price of the securities being registered for resale and the percentage that these shares currently represent of the total number of shares outstanding. Also disclose that even though the current trading price is significantly below the SPAC IPO price, the private investors have an incentive to sell because they will still profit on sales because of the lower price that they purchased their shares than the public investors. Management's Discussion and Analysis of Financial Condition, page 82 5.We note that the projected revenues for 2023 were €440.3 million, as set forth in the unaudited prospective financial information management prepared and provided to the Board, the company’s financial advisors and the SPAC in connection with the evaluation of the Business Combination. We also note the disclosure on page 135 of the Form F-4 regarding the changes in assumptions underlying the projections and that you believe projected volumes for 2024 continue to be reasonable. We also note that your actual revenues for the Six Months Ended June 30, 2023 was approximately €256,000. It appears that you will miss your 2023 revenue projection and it appears you will also miss 2024 revenue projections. Please update your disclosure in Liquidity and Capital Resources, and elsewhere, to provide updated information about the company’s financial position and further risks to the business operations and liquidity in light of these circumstances. 6.Please expand your discussion here to reflect the fact that this offering involves the potential sale of a substantial portion of shares for resale and discuss how such sales could impact the market price of the company’s common stock. Your discussion should highlight the fact that ND Group, B.V., a beneficial owner of over 45% of your outstanding shares, will be able to sell all of its shares for so long as the registration statement of which this prospectus forms a part is available for use. General 7.Revise your prospectus to disclose the price that each selling securityholder paid for the shares being registered for resale. Highlight any differences in the current trading price, the prices that the selling securityholders acquired their shares, and the price that the

FirstName LastNameEelco Van Der Leij Comapany NameNext.e.GO N.V. December 1, 2023 Page 3 FirstName LastName Eelco Van Der Leij Next.e.GO N.V. December 1, 2023 Page 3 public securityholders acquired their shares. Disclose that while the selling securityholders may experience a positive rate of return based on the current trading price, the public securityholders may not experience a similar rate of return on the securities they purchased due to differences in the purchase prices and the current trading price. Please also disclose the potential profit the selling securityholders will earn based on the current trading price. Lastly, please include appropriate risk factor disclosure. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Gregory Herbers at 202-551-8028 or Geoffrey Kruczek at 202-551-3641 with any other questions. Sincerely, Division of Corporation Finance Office of Manufacturing cc: Clemens Rechberger

Show Raw Text
United States securities and exchange commission logo
December 1, 2023
Eelco Van Der Leij
Executive Director
Next.e.GO N.V.
Lilienthalstraße 1
52068 Aachen, Germany
Next.e.GO N.V.
Re:Next.e.GO N.V.
Registration Statement on Form F-1
Filed November 14, 2023
File No. 333-275553
Dear Eelco Van Der Leij:
            We have conducted a limited review of your registration statement and have the
following comments.
            Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
            After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments.
Form F-1 filed November 14, 2023
Cover Page
1.For each of the securities being registered for resale, disclose the price that the selling
securityholders paid for such securities.
2.Disclose the exercise price of the warrants compared to the market price of the underlying
security. If the warrants are out the money, please disclose the likelihood that warrant
holders will not exercise their warrants. Provide similar disclosure in the prospectus
summary, risk factors, MD&A and use of proceeds section and disclose that cash proceeds
associated with the exercises of the warrants are dependent on the stock price. As
applicable, describe the impact on your liquidity and update the discussion on the ability
of your company to fund your operations on a prospective basis with your current cash on
hand.

 FirstName LastNameEelco  Van Der Leij
 Comapany NameNext.e.GO N.V.
 December 1, 2023 Page 2
 FirstName LastNameEelco  Van Der Leij
Next.e.GO N.V.
December 1, 2023
Page 2
3.We note the significant number of redemptions of your common stock in connection with
your business combination and that the shares being registered for resale will constitute a
considerable percentage of your public float. We also note that all or most of the shares
being registered for resale were purchased by the selling securityholders for prices
considerably below the current market price of the common stock. Highlight the
significant negative impact sales of shares on this registration statement could have on the
public trading price of the common stock.
Risk Factors, page 18
4.Include an additional risk factor highlighting the negative pressure potential sales of
shares pursuant to this registration statement could have on the public trading price of the
common stock. To illustrate this risk, disclose the purchase price of the securities being
registered for resale and the percentage that these shares currently represent of the total
number of shares outstanding. Also disclose that even though the current trading price
is significantly below the SPAC IPO price, the private investors have an incentive to sell
because they will still profit on sales because of the lower price that they purchased their
shares than the public investors.
Management's Discussion and Analysis of Financial Condition, page 82
5.We note that the projected revenues for 2023 were €440.3 million, as set forth in the
unaudited prospective financial information management prepared and provided to the
Board, the company’s financial advisors and the SPAC in connection with the evaluation
of the Business Combination.  We also note the disclosure on page 135 of the Form F-4
regarding the changes in assumptions underlying the projections and that you believe
projected volumes for 2024 continue to be reasonable. We also note that your actual
revenues for the Six Months Ended June 30, 2023 was approximately €256,000. It appears
that you will miss your 2023 revenue projection and it appears you will also miss 2024
revenue projections. Please update your disclosure in Liquidity and Capital Resources,
and elsewhere, to provide updated information about the company’s financial position and
further risks to the business operations and liquidity in light of these circumstances.
6.Please expand your discussion here to reflect the fact that this offering involves the
potential sale of a substantial portion of shares for resale and discuss how such sales could
impact the market price of the company’s common stock. Your discussion should
highlight the fact that ND Group, B.V., a beneficial owner of over 45% of your
outstanding shares, will be able to sell all of its shares for so long as the registration
statement of which this prospectus forms a part is available for use.
General
7.Revise your prospectus to disclose the price that each selling securityholder paid for the
shares being registered for resale. Highlight any differences in the current trading price,
the prices that the selling securityholders acquired their shares, and the price that the

 FirstName LastNameEelco  Van Der Leij
 Comapany NameNext.e.GO N.V.
 December 1, 2023 Page 3
 FirstName LastName
Eelco  Van Der Leij
Next.e.GO N.V.
December 1, 2023
Page 3
public securityholders acquired their shares. Disclose that while the selling
securityholders may experience a positive rate of return based on the current trading price,
the public securityholders may not experience a similar rate of return on the securities
they purchased due to differences in the purchase prices and the current trading price.
Please also disclose the potential profit the selling securityholders will earn based on the
current trading price. Lastly, please include appropriate risk factor disclosure.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
            Please contact Gregory Herbers at 202-551-8028 or Geoffrey Kruczek at 202-551-3641
with any other questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc:       Clemens Rechberger